A Randomized Placebo-Controlled Trial of Nicotinamide Riboside in Older Adults with Mild Cognitive Impairment Clinical, Neurological HealthANAD StaffNovember 23, 2023Neurological Health, Mild Cognitive Impairment
Long-Term Nicotinamide Riboside Use Improves Coordination and Eye Movements in Ataxia Telangiectasia Clinical, Neurological Health, Ataxia TelangiectasiaANAD StaffOctober 29, 2023Ataxia Telangiectasia, Neurological Health
Nicotinamide Riboside Supplementation is Not Associated with Altered Methylation Homeostasis in Parkinson’s Disease Clinical, Neurological Health, MethylationANAD StaffMarch 17, 2023Neurological Health, Parkinson's Disease, Methylation
Combined Metabolic Activators Improve Cognitive Functions in Alzheimer’s Disease Patients: A Randomized, Double-Blinded, Placebo-Controlled Phase-II Trial Clinical, Alzheimer's Disease, Neurological HealthANAD StaffJanuary 26, 2023Neurological Health, Alzheimer's Disease
Oral Nicotinamide Riboside Raises NAD+ and Lowers Biomarkers of Neurodegenerative Pathology in Plasma Extracellular Vesicles Enriched for Neuronal Origin Clinical, Neurological HealthANAD StaffDecember 14, 2022Neurological Health
The NADPARK Study: A Randomized Phase I Trial of Nicotinamide Riboside Supplementation in Parkinson’s Disease Clinical, Neurological HealthANAD StaffMarch 1, 2022Parkinson's Disease, Neurological Health
